首页> 外文期刊>Neurochemical research >Mitochondrial Division Inhibitor 1 Ameliorates Mitochondrial Injury, Apoptosis, and Motor Dysfunction After Acute Spinal Cord Injury in Rats
【24h】

Mitochondrial Division Inhibitor 1 Ameliorates Mitochondrial Injury, Apoptosis, and Motor Dysfunction After Acute Spinal Cord Injury in Rats

机译:线粒体分裂抑制剂1可减轻大鼠急性脊髓损伤后的线粒体损伤,细胞凋亡和运动功能障碍

获取原文
获取原文并翻译 | 示例
           

摘要

Mitochondrial division inhibitor 1 (Mdivi-1) is the most effective pharmacological inhibitor of mitochondrial fission. Spinal cord injury (SCI) is a common and serious trauma, which lacks efficient treatment. This study aimed to detect the role of Mdivi-1 in neuronal injury and its underlying mechanism after acute SCI (ASCI) in rats. Western blot analysis showed that Bax levels on the mitochondrial outer membrane, and release of cytochrome C (cytC) and apoptosis-inducing factor (AIF) from the mitochondria began to increase significantly at 4 h after ASCI, then peaked at 16 h, and declined significantly from 16 to 24 h. However, the mitochondrial levels of Bcl-2 increased significantly at 2 h, peaked at 4 h, and subsequently significantly decreased from 4 to 24 h after ASCI. In addition, Mdivi-1(1.2 mg/kg) significantly suppressed the translocation of dynamin-related protein 1 (Drp1) and Bax to the mitochondria, mitochondrial depolarization, decrease of ATP and reduced Glutathione, increase of the Malondialdehyde, cytC release, and AIF translocation at 16 h and 3 days after ASCI, and also inhibited the caspase-3 activation and decrease of the percentage of apoptotic cells at 16 h, 3 and 10 days, further, ameliorated the motor dysfunction greatly from 3 to 10 days after ASCI in rats. This neuroprotective effect was dose-dependent. However, Mdivi-1(1.2 mg/kg) had no effects on the translocation of Bcl-2 and fission protein 1 on the mitochondria, and did not affect the expression of total Drp1 at 16 h after ASCI. Our experimental findings indicated that Mdivi-1 can protect rats against ASCI, and that its underlying mechanism may be associated with inhibition of Drp1 translocation to the mitochondria, alleviation of mitochondrial dysfunction and oxidative stress, and suppression of caspase-dependent and -independent apoptosis.
机译:线粒体分裂抑制剂1(Mdivi-1)是线粒体裂变最有效的药理抑制剂。脊髓损伤(SCI)是常见且严重的创伤,缺乏有效的治疗方法。本研究旨在检测Mdivi-1在大鼠急性SCI(ASCI)后神经元损伤中的作用及其潜在机制。 Western印迹分析表明,线粒体外膜上的Bax水平以及线粒体中细胞色素C(cytC)和细胞凋亡诱导因子(AIF)的释放在ASCI后4 h开始显着增加,然后在16 h达到峰值,然后下降从16到24小时明显。然而,Bcl-2的线粒体水平在2h时显着增加,在4h时达到峰值,随后在ASCI后4至24h显着下降。此外,Mdivi-1(1.2 mg / kg)显着抑制了动力相关蛋白1(Drp1)和Bax向线粒体的转运,线粒体去极化,ATP的降低和谷胱甘肽的减少,丙二醛的增加,cytC的释放以及在ASCI后16 h和3天发生AIF易位,并在caspase-3激活后16 h,3和10天抑制caspase-3活化和凋亡细胞百分比的降低,进一步改善了ASCI后3至10天的运动功能障碍在大鼠中。这种神经保护作用是剂量依赖性的。然而,Mdivi-1(1.2 mg / kg)对线粒体中Bcl-2和裂变蛋白1的转运没有影响,并且对ASCI后16 h总Drp1的表达没有影响。我们的实验结果表明Mdivi-1可以保护大鼠免受ASCI侵害,其潜在机制可能与抑制Drp1易位至线粒体,减轻线粒体功能障碍和氧化应激以及抑制caspase依赖性和非依赖性凋亡有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号